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APPLICATIONS OF MANGANESE-ENHANCED MAGNETIC RESONANCE 
IMAGING IN NEUROSCIENCE 
 
 
ABSTRACT 
 
 
 
 Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) has proven itself 
to be a beneficial technique in the field of Neuroscience.  This thesis applies MEMRI to 
studies in neuroscience by first establishing the limitations concerning the use of MEMRI 
in live rats. Experiment 1 used an osmotic pump for manganese (Mn) delivery to the 
lateral ventricles for acquisition of anatomical images using MEMRI. From my 
knowledge, this was the first method demonstrating slow infusion of Mn to the lateral 
ventricles. In Experiment 2, MEMRI was used for volumetric analysis the whole brain 
and hippocampus of prenatally stressed rats. To my knowledge, this study was the first to 
investigate the effect of generational prenatal stress on the structure of a rat’s brain using 
MEMRI and histology. Additionally, Experiment 2 investigated the use of a 
subcutaneous osmotic pump to deliver Mn for MEMRI. A summary on the use of 
MEMRI in Neuroscience concludes this thesis, with a discussion on the methods used 
and related technical considerations.  
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CHAPTER 1 
 
Introduction  
 
1.1 Introduction to Magnetic Resonance Imaging 
Anatomical and functional mapping of the brain has been a fundamental goal of 
modern neuroscience since the early 1900’s. In the past three decades, the magnetic 
resonance imaging technique has emerged as the single most powerful neuroimaging tool 
to accomplish this goal. Advances in magnetic resonance imaging give exceptional 
information on the anatomy, physiology and functional processes of the brain. The search 
for methods of obtaining more detailed physiological, molecular and functional 
information from magnetic resonance imaging (MRI) is becoming more prominent and 
the interest in the use of new contrast agents is increasing.  
MRI uses the principles of nuclear magnetic resonance (NMR) which was first 
observed in bulk matter by Felix Bloch and Edward Purcell in 1946 (Bloch et al., 1946, 
Purcell et al., 1946). NMR originates from the interactions between microscopic nuclear 
magnetic moments and externally applied magnetic fields. For a nucleus to have a 
magnetic moment, it must have a net angular momentum and charge. Spin is a 
fundamental property of sub-atomic particles like the nucleus. Nuclear spin is analogous 
to angular momentum at the quantum level and is described by integer or half integer (½, 
1, 3/2 …) values of a discrete quantized amount of angular momentum.  Protons and 
electrons each have a spin of ½ and are  either positively  or negatively charged (Keevil, 
2001), thus they poses a magnetic moment and can produce NMR signals.  For the 
purpose of introducing MRI in this thesis, the focus will be on hydrogen nuclei. The 
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nucleus of the hydrogen atom, consisting of a single proton, is the target of MRI because 
of its high NMR sensitivity and because of its abundance in the body.  
 When a group of nuclei is placed in an external magnetic field (B0) the magnetic 
moments of the nuclei will align either parallel or anti-parallel to the field (Figure 1.1). In 
equilibrium, the net magnetic moments or magnetization occurs only along the 
longitudinal axis, or z-axis (direction of the constant magnetic field). This is because the 
parallel alignment is at a lower energy state and thus has a higher probability of being 
populated.  
 
 
 
 
 
 
 
 
 
 
The magnetization can be displaced away from the z-axis by the application of a 
transverse oscillating magnetic field (B1) at a specific frequency (Figure 1.1). Any 
magnetization that is in the transverse plane will oscillate or precess about the z-axis due 
to the interaction with the B0 field. The frequency of this precession is directly 
proportional to the B0 field at that location and is called the Larmor frequency. This 
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Figure 1.1: Magnetic moments (small arrows) of the nuclei (circles) are aligned 
randomly when outside a strong magnetic field. When placed in an external magnetic 
field (B0), nuclei align parallel and anti-parallel to the field. The magnetization is then 
displaced by applying a transverse oscillating field.  
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oscillating magnetization induces current in the MRI receiver coil and this is the 
oscillating transverse magnetization that gives rise to the signal that is detected by MRI. 
The frequency range of MRI signals is near that of radio receivers (10 - 900 Mhz) and is 
said to be at radio frequencies (RF).  By adding linear magnetic field gradients, multiple 
Larmor frequencies are produced that encode the spatial locations of the nuclei. The 
signal becomes a mixture of frequencies that are mathematically (Fourier) transformed to 
produce the image (Huettel, 2009). The intensity and thus the contrast at each location in 
the image is dependent on the T1 and T2 relaxation.  
 
1.1.1  T1 and T2 Relaxation  
When the B1 field is turned off, the molecules begin to return to their equilibrium 
configuration. The transverse component decays and the longitudinal component recovers 
back to its original magnitude. This is known as relaxation. Relaxation is associated with 
redistribution of energy within the spin system and the loss of energy to the surroundings 
or “lattice”. The time constant that describes the rate of recovery of the longitudinal 
component to its original position is called T1 relaxation or spin-lattice relaxation. The 
measure of the decay of the transverse component over time is called T2 relaxation or 
spin-spin relaxation. Relaxation affects the magnitude of the magnetization that is 
detected by a receive coil in the MRI scanner. Thus, the information gathered by the 
scanner is: 1) the energy release; 2) T1 relaxation; and 3) T2 relaxation (Keevil, 2001).  
The maximum energy release is an estimate of the number of observable 
hydrogen nuclei which ultimately corresponds to the amount of water in the tissue 
sample. T1 and T2 relaxation times depend on the efficiency of energy exchange at the 
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microscopic level. The mechanism of this exchange is magnetic coupling to the spin 
system. Since the spin system is placed into a magnetic field and thus has an energy 
splitting directly proportional to the Larmor frequency, the most efficient energy 
exchange happens when fluctuations occur near the Larmor frequency. The nucleus can 
be thought of as a very sensitive probe of the dynamics of its immediate magnetic 
surroundings. Relaxation can be affected by chemical bonding, viscosity, molecular size 
and molecular motions and reflects the surroundings of each individual atom.  
Using the properties of T1 and T2 relaxation, it is possible to emphasize tissues 
that show different characteristics in relaxation times. MR Images in which contrast is 
associated with differences in T1 relaxation times are called T1-weighted whereas 
contrast linked to differences in T2 relaxation times are called T2-weighted images. 
 
1.1.2 Image Acquisition 
1.1.2.1  T1- and T2-weighted Images 
 In order to achieve T1-weighted and T2-weighted images, one can use a variety of 
pulse sequences. In these experiments, the Spin Echo sequence was used.  
The Spin Echo sequence is based on a pulse sequence consisting of a 90 degree 
RF pulse followed by a 180 degree RF pulse (Figure 1.2). The application of this pair of 
pulses, 90 followed by 180 degree, results in a spin echo forming at a time equal to the 
interval between the first and second pulse (Hahn, 1950). Echo time (TE) is the time 
between the 90 degree pulse and the time where the echo forms. The two pulses are 
repeated and thus the repetition time (TR) is the time between the two successive 90 
degree pulses. Figure 1.2 illustrates both TE and TR times. 
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After excitation, the longitudinal magnetization is rotated down to the transverse 
(xy) plane. As the spins lose energy, the longitudinal magnetization then recovers back to 
its original state according to the T1 relaxation time. TR determines how much 
longitudinal magnetization can recover between cycles which is proportional to the T1 
contrast (Huettel, 2009). During the TE, the transverse magnetization decays according to 
the T2 relaxation time, due to loss of coherence among the spins. TE determines how 
much the transverse signal decays (Huettel, 2009). 
 
 
 
 
 
 
 
 
 
 
By selecting combinations of TE and TR, the contrast dependence in the image 
can be weighted towards T1 or T2.  For a T2-weighted image, a TE usually greater than 
60 ms with a long TR is used. For a T1-weighted image, a short TE and a TR less than 
the tissue T1s is used. General times are as follows; T1 weighted: short TE (smaller than 
12 ms) and short TR (300-600 ms); T2 weighted: long TE (greater than 60 ms) and long 
TR (greater than 1600 ms) (Bitar et al., 2006).  
Figure 1.2: Spin-Echo Pulse sequence illustrating the TE time and the TR time with 
regards to the 90 degree and 180 degree pulses.     
 
 
90
o
 
180
o
 
TR 
TE 
 RF Pulse  
Echo 
Formation 
90
o
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1.1.2.2.    T1 and T2 Mapping  
The quantitative imaging approach focuses on measuring the values of the tissue 
relaxation properties (T1 and T2). This includes collecting a set of images from which the 
relaxation parameters can be calculated based on a theoretical model. Such a calculated 
image will be referred to as a map. Mapping provides sensitivity to the full range of T1 
and T2s, and has the potential to quantify the tissue concentrations of a contrast agent. 
For the purpose of this thesis, the relaxivity of manganese (introduced below) in tissue is 
measured mainly using the mapping of T1.  
T1 maps can be generated from sets of saturation recovery images with varying 
saturation times. The saturation time is the time between a 90 degree preparation pulse 
and the image acquisition. The image intensity at any location is described by Equation 
1.1, where I is equal to intensity, I0 is the equilibrium intensity, TR is the repetition time, 
T1 is the relaxation time and a is equal to 1 for 90 degree pulse and 2 for an inversion 
(180 degree) preparation. 
    
        Equation 1.1 
 
Any non-linear curve fitting procedure can be used to calculate the parameters 
that best match the data to the equation. This is performed for each pixel position in the 
data set. The calculated T1 values are displayed as gray scale intensities to make up the 
T1 map. 
T2 maps are generated using a set of images with the same TR but multiple TE’s. 
The image intensity is described by Equation 1.2, where TE is equal to the set of echo 
I=Io(1-ae
-TR/T
1) 
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times and T2 is equal to the relaxation time. Through the fitting procedure the two 
parameters are assigned.  
         
        Equation 1.2 
 
 
1.1.3 Introduction to Paramagnetics  
Paramagnetic materials (e.g. Mn
2+
, Gd
3+
) have unpaired electrons which result in 
a net magnetic moment. The longitudinal T1 relaxation time and transverse T2 relaxation 
time of the protons are determined by molecular motions that produce fluctuating local 
magnetic fields. The protons interact with each other through dipole-dipole interactions. 
Since the magnetic dipole produced by an electron is much stronger that that produced by 
the nucleus, the interaction is dominated by a dilute number of paramagnetic ions. The 
relaxation rates (1/relaxation times) are linearly dependent on the concentration of the 
paramagnetic substance.  
The metal manganese, in the form of its divalent ion, Mn
2+
 (for brevity, Mn will 
be used for the remainder of this thesis) is paramagnetic and causes strong reduction of 
both T1 and T2 relaxation time constants of tissue water (Silva and Bock, 2008). The 
extent of T1 or T2 reduction depends on the local Mn concentration and can be described 
by:  
      Rio = Rt(0) + Ri [Mn
2+
]            Equation 1.3 
 
I=Ioe
-TE/T
2 
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Where Rio = 1/Ti (i=1,2) is the observed relaxation rate, [Mn
2+
] is the concentration  of 
the Mn
2+
 ion, Ri is the relaxivity constant, and Rt(0) is the relaxation rate of the solvent 
without manganese ([Mn
2+
] = 0).  
 The significance of this magnetization is that some paramagnetics can be 
delivered to the body and used as contrast agents. This is commonly done in clinical 
imaging (e.g. using gadolinium for enhancing tumors of the liver, kidney etc…). The use 
of manganese and its unique properties as a contrast agent in MRI is known as MEMRI. 
 
1.2 Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) 
The use of manganese as a contrast agent for the use in animal studies is a 
relatively recent advance in MRI studies. The properties, issues of toxicity, delivery 
routes and commonly used concentrations of manganese will first be introduced followed 
by an introduction to the use of MEMRI in the current literature. 
 
1.2.1 Properties of Manganese 
Manganese (Mn) is an essential heavy metal that is ubiquitous in nature. It plays 
important roles in the metabolism and synaptic function as an antioxidant and enzymatic 
cofactor in the brain (Chuang et al., 2009b). Mn is an important co-factor in a number of 
key enzymes, including manganese superoxide dismutase, pyruvate carboxylase and 
glutamine synthetase (Silva and Bock, 2008).  
However, while Mn in trace amounts is an essential ion for normal cellular 
functioning, chronic overexposure to the metal can lead to a progressive and permanent 
neurodegenerative disorder in humans and nonhuman primates called “manganism” 
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(Roth, 2006). Manganism resembles the main pathological features of Parkinson’s 
disease (Silva and Bock, 2008). Excess Mn damages the central nervous system by a 
number of mechanisms, including inhibition of mitrochondrial oxidative phosphorylation 
(Chuang et al., 2009b). In addition to the deleterious effects of chronic overexposure, 
acute overexposure to Mn (such as by injection of Mn substance systemically in an 
experimental model) can also lead to hepatic failure and cardiac toxicity (Silva and Bock, 
2008). 
The simplest way to administer of Mn is to use a MnCl2 solution (Silva and Bock, 
2008). According to the Material Safety Data Sheet (MSDS) for MnCl2, the target organs 
include the central nervous system and the lungs, and characteristic signs and symptoms 
of exposure have been identified. Silva et al., 2004 states that ‘men exposed to 
manganese dusts showed a decrease in fertility with early symptoms including languor, 
sleepiness and weakness in the legs.’ Regardless of these toxicity issues, researchers 
continue to find ways of avoiding Mn’s toxic effects so that they can benefit from its 
paramagnetic properties.  
In order to reduce some of the toxic effects of manganese, researchers must also 
take into consideration the osmolarity and the pH of the solution which should be 
biocompatible with the organism or tissue of interest. The osmolarity of most 
extracellular body fluids is about 300 mOsm. Because MnCl2 consists of 3 ions, a 100 
mM MnCl2 solution would result in an isotonic solution. Unbuffered aqueous solutions of 
MnCl2 are slightly acidic. Thus, the pH of MnCl2 needs to be controlled by adjustment to 
values near 7.4 using sodium hydroxide or by preparing manganese solutions with a 
buffer such as bicine or Tris-HCL (Seo et al., 2011a). 
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Toxicokinetic parameters such as half-lives, uptake times and clearance rates have 
recently been studied (Zheng et al., 2000). Along with the methods above, considering 
these parameters can also help in determining a less toxic dosing regime for MEMRI. It 
has been shown that there is a long half-life of manganese in the brain (51–74 days) 
relative to its short half-life in visceral organs like the heart and the liver (Takeda et al., 
1995). It was also found that when injected systemically Mn has a total body (not 
including brain) clearance rate of 0.43 L/h/kg and a blood terminal elimination of 1.83 h 
(Zheng et al., 2000). Taking this into consideration, it has been proposed to apply MnCl2 
in a fractionated manner (i.e. smaller doses more often) to reach a sufficient Mn 
accumulation while minimizing toxic side effects (Takeda et al., 1995; Bock et al., 2008).  
The issues of MnCl2 toxicity requires a compromise between avoiding toxicity 
and delivering adequate amounts of manganese for MEMRI (Silva and Bock, 2008). The 
goal of optimizing MEMRI signal enhancement and strategies for efficient delivery of 
Mn to the brain, while minimizing toxicity to the animal creates the question  of the 
optimum methodology to use in MEMRI experiments (Silva et al., 2004). 
Questions regarding the most efficient route of administration and the most 
effective concentration to use have yet to be answered. Below, I will summarize some 
common delivery routes and concentrations described in the current literature. 
 
1.2.2   Manganese Delivery Routes  
 In order to increase the successful application of MEMRI, the delivery of Mn to 
the site of interest must be considered. In animals, Mn
 
can be injected intravenously (IV), 
subcutaneously (SQ), intraperitoneally (IP) or as an injection directly into the area of 
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interest (i.e. the brain). The simplest way to deliver Mn is to inject a solution of the salt 
MnCl2 (Silva and Bock, 2008). After injection, MnCl2 dissociates into Mn
2+
 and Cl
-
.  
The routes of delivery, systemic or local cerebral administration, are applied for 
different reasons: 1) systemic administration which reaches the brain via the blood, 
enhances cerebral cytoarchitecture that would otherwise be difficult to reveal as well as 
to demarcate active regions of the brain; and 2) local cerebral administration enables one 
to map neuronal tracts in the living brain where Mn is stored and transported along 
axonal tracts (Bouilleret et al., 2011). 
 
1.2.2.1 Systemic Administration 
The earliest work with Mn as an MRI contrast agent relied on giving a systemic 
dose of MnCl2 and monitoring distribution in a number of tissues. It was discovered that 
Mn accumulates in almost all tissues when administered systemically (Kang and Gore, 
1984). One study investigated the relative MRI enhancement obtained with different 
systemic routes of administration (SQ, IP) and concluded that both the temporal and 
regional changes in cerebral T1 relaxation following MnCl2 infusion are relatively 
independent of the route of administration (Kuo et al., 2005).  
Systemic application of Mn leads to an accumulation in specific brain areas 
including the basal ganglia, hippocampus, pituitary gland, cerebellum and olfactory bulb 
(Silva et al., 2004).  The tissue-specific accumulation of Mn is dependent on the cerebral 
spinal fluid (CSF)-brain transport mechanisms from the lateral ventricles leading to a 
facilitated uptake in adjacent areas (Bock et al., 2008a). Also, it has been shown that the 
distribution of manganese may reflect the density of astrocytes (Henriksson et al., 2000), 
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neurons (Paulter et al., 1998), or mitochondria (Akai et al., 1990, Gavin et al., 1990). It is 
known that Mn ions cannot passively enter the brain parenchyma through an intact blood 
brain barrier (BBB) (Aoki et al., 2004a). Mn, however, can slowly diffuse into brain 
parenchyma via the blood-CSF barrier (BCB) present at the choroid plexus in ventricles 
(Aoki et al., 2004a). This distribution of manganese eventually leads to enhancement in 
multiple brain regions.    
One downfall of using a systemic Mn injection is that before it reaches the brain, 
it is absorbed by the liver, heart and kidneys. This can cause many acute toxic effects 
including compromised cardiovascular function, renal failure and liver failure. This is 
why, is some cases, it is safer to use an administration of Mn focally as it could reduce 
some of these toxic effects. 
 
1.2.2.2 Local Injection  
For a more direct administration, focal injections are often used to target areas of 
interest, primarily in the brain. A range of recent studies have used direct injections of 
Mn to trace neuronal connections in rodents (Table 1.1). Due to the fact that Mn is a 
calcium (Ca
2+
) analogue, in the CNS,  Mn can enter excitable cells via voltage-gated Ca
2+
 
channels, the sodium (Na
+
)/Ca
2+
 exchanger, the Na
2+
/ magnesium (Mg
2+
) antiporter and 
the active Ca
2+
 uniporter in mitochondria (Paulter, 1998). Once inside cells, some Mn is 
packaged in the endoplasmic reticulum and is transported anterogradely along 
microtubules in axonal tracts (Pautler, 2006) . Upon reaching the presynaptic membrane, 
it is released into the synaptic cleft along with the neurotransmitter glutamate (Silva and 
Bock, 2008). 
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As stated above, focal injections are beneficial as the issue of toxicity is less 
severe in MEMRI experiments that use a local injection of MnCl2 in the brain because 
there is little exposure to Mn outside of the injection site (as opposed to systemic 
circulation) and immediately adjacent areas. It also allows for a marked reduction of the 
total amount of applied manganese. 
 
1.2.3 Concentrations of MnCl2 Solutions  
A systemic dose ranging from 9-175 mg/kg, either in one bolus injection or 
multiple injections (Table 1), have been used in MEMRI. This wide range of doses leads 
to MRI detection of the basal ganglia, hippocampus, pituitary gland, cerebellum and 
olfactory bulb (Silva et al., 2004). Contrast enhancement increases with increasing doses 
of MnCl2. In general both the contrast as well as the signal intensity of the enhanced 
regions are increased, allowing for better distinction of anatomical features (Silva et al., 
2004). In focal injections, concentrations ranging from 2-9 mg/kg (Table 1) lead to MRI 
detection in the areas of interest.  
The MSDS for MnCl2 shows that acute systemic doses as low as 93 mg/kg in rats 
have significant adverse effects including high mortality rates. However, recent MEMRI 
experiments (Table 1.1) have safely used similar doses, or even higher doses, with 
manageable or no adverse effects. Unfortunately, MRI studies do not necessarily include 
a formal behavioural test and the  assessment of potential toxic effects are usually limited 
to a “subjective general observation” of animal behavior in the home cage (Eschenko et 
al., 2010b). Also, it is unlikely, that animal models of brain disease will tolerate these 
high doses. Additionally, in studies which concern the use of behavioural or neurological 
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testing, high concentrations may affect behavioural outcomes and thus may not be ideal 
for in vivo studies. High doses are also not advisable for longitudinal studies which 
require repeated injections (Silva and Bock, 2008). In these cases, research groups have 
begun to use (and recommend – Eschenko et al., 2010b) a slow release delivery system 
achieved with the use of an osmotic pump. 
 
Table 1.1: Summary of injection routes and doses, ordered by method of injection. 
Reference: Concentration in mg/kg  Concentration in  
mM 
Method of Injection  
Lin and Koretsky (1997) 54 mg/kg    Intravenous 
Aoki et al. (2004c) 175 mg/kg   Intravenous  
Cross et al. (2009) 
 
75 mg/kg    Tail Vein  
Chuang et al. (2009a) 175 mg/kg   Tail Vein  
de Sousa et al. (2007) 175 mg/kg   Tail Vein  
Aoki  et al.  (2002)  
 
53 mg/kg  Intra-arterial  
(Inui-Yamamoto et al., 
2010) 
 
20 mg/kg   Intra-peritoneal 
Tambalo et al. (2009) 
 
 270 mM 
0.2 mmol/kg 
Intra-peritoneal 
Jackson et al. (2011) 40 mg/kg  Intra-peritoneal 
Bouilleret et al. (2011) 100 mg/kg  Intra-peritoneal 
Eschenko et al. (2010a) 16 mg/kg –32 mg/kg – 80 
mg/kg  
 Subcutaneous 
 
 
Eschenko et al. (2010b) 16 mg/kg 
80 mg/kg 
 Subcutaneous 
McCreary 2011 7.14 mg/kg   Lateral Ventricle  
Seo et al. (2011a) 7.14 mg/kg 100 mM 
2 mM  
rate 180 µL/kg/hr 
Left Lateral Ventricle  
Seo et al. (2011b)  0.1 umol/h Left lateral ventricle  
van der Zijden et al. 
(2008) 
 0.2 uL  
1 mol/L 
0.05 uL/min 
Sensorimotor cortex  
Yang et al. (2011)  120 mmol/L Right medial thalamus  
Sandvig et al. (2011)  3 uL of 150 nmol Intravitreal 
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1.2.4 Use of Osmotic Pumps to Deliver Manganese 
 Some research groups have started to use slow release mechanisms such as the 
osmotic pump to deliver Mn (Canals et al., 2008, Eschenko et al., 2010a). The use of 
osmotic pumps to deliver a specific concentration of Mn over a specified period of time 
could decrease many of the toxicity issues which one must face when dealing with 
MEMRI experiments. In some cases, an osmotic pump enables an increase in Mn
 
concentration (and therefore a greater Signal to Noise Ratio [SNR]) while keeping the 
toxicity of the ion to a minimum. Canals et al. (2008) demonstrated that Mn doses that 
resulted in dramatic cortical lesions when injected acutely into the brain parenchyma, can 
safely be applied to the brain when delivered at a constant and slow infusion rate (Canals 
et al., 2008) . The present experiments use the ALZET ® (Alzet, Durect) osmotic pump 
(Figure 1.3).   
 
 
 
 
 
 
 
 
 
ALZET pumps operate due to an osmotic pressure difference between a 
compartment within the pump, and the tissue environment in which the pump is 
Figure 1.3:  ALZET pump (A) attached to a vinyl catheter (B) connected to a cannula 
(C). Flow moderator (inside pump) controls the amount of solution delivered from the 
pump to the cannula or external environment. Osmotic pump is inserted subcutaneously 
whereas a cannula, for focal injections can be implanted to the brain region of interest.    
C 
A 
B 
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implanted. As water enters from the body into the pump compartment, it compresses the 
flexible reservoir, displacing the MnCl2 solution from the pump at a controlled, 
predetermined rate. ALZET provides a variety of delivery rates, and these pumps can 
administer the solution in the same fashion as a syringe (SQ or IP implant, cannulation to 
brain) (Theeuwes and Yum, 1976).     
 
1.2.5   The Use of MEMRI in Neuroscientific Studies 
MEMRI with systemically injected MnCl2 has proven to be a promising technique 
for brain imaging in live animals. There are several features that suggest that Mn infusion 
is uniquely suited for brain imaging (Eschenko et al., 2001).  
 Divalent Mn is paramagnetic and reduces the T1 relaxation times of water 
protons. This feature enhances specific cytoarchitectural characteristics using Mn as a 
contrast agent. Many studies have benefited from this technique as they are able to detect 
specific neuroarchitectonic features in the rodent brain using MRI after systemic MnCl2 
administration (Lin and Koretsky., 1997, Aoki et al., 2004b, de Sousa et al., 2007, 
Jackson et al., 2011). One study showed the development of the rat brain and measured 
T1 at several stages of rat brain development in the presence of Mn (de Sousa et al., 
2007). Another study compared the uptake of Mn in a marmoset brain versus a rat brain 
and found differences in the structures which had the highest enhancement (Bock et al., 
2008). Most recently, Jackson et al. (2011) used Mn to study hippocampal structure and 
function in parallel with cognitive testing. They applied behavioural testing to investigate 
if the Mn disrupted hippocampus-dependent behaviour and found that it did not have 
adverse effects on behaviour (Jackson et al., 2011). 
17 
 
Secondly, Mn can reflect anatomical connectivity as it is taken up by cells and 
anterogradely transported along neural pathways. In 1998, Paulter and colleagues utilized 
the paramagnetic properties of Mn, performing the first in vivo Mn tract tracing 
experiment (Pautler et al., 1998) . They showed that administration of MnCl2 into the rat 
and mice olfactory receptor neurons leads to contrast enhancement in the olfactory bulb 
and primary olfactory cortex in MRI. Since this first experiment, MEMRI has been used 
to trace several pathways including the visual optic tract in rats (Murayama et al., 2006), 
olfactory tract in rats (Cross et al., 2004) and hippocampal pathways in rats, mice and 
monkeys (Watanabe et al., 2001, Chen et al., 2007) as well as the song center in birds 
(Van der Linden et al., 2009).  
 Finally, Mn is transferred through voltage-gated channels to neurons at fairly low 
rates and therefore its accumulation is relatively proportional to neural activity. For this 
reason, Van der Linden et al. (2007) reported that activation in awake moving animals 
can be monitored by performing MRI after the presumed activity has occurred, when 
preceded by an intraperitoneal injection of Mn. Mn will accumulate in activated areas of 
the brain, and MEMRI can be used to investigate such areas after an external stimulation. 
For example, stimulation of whisker barrels in rats shows a clear relationship between 
manganese-enhanced cortical regions and whisker tactile-sensory-evoked activity (Weng 
et al., 2007). Yet another study used MEMRI to map the auditory brainstem in mice (Yu 
et al., 2005).   
MEMRI has been used in previous studies. Nevertheless, although previous 
studies highlight the potential of MEMRI for brain imaging, the limitations and 
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boundaries concerning the use of Mn in living animals and its applications in behavioural 
neuroscience are only beginning to be characterized. 
 
1.3 Thesis Objectives and Rationale 
The main objective of the thesis is to apply MEMRI to studies in neuroscience by 
first establishing the limitations concerning the use of MEMRI in live rats.  
 
 
The major objectives of this thesis include:  
 
 
1) Develop an MEMRI protocol in rats for direct injection of Mn into the lateral 
ventricle using a cannula and an implanted osmotic pump system. 
2) Determine the neurotoxicity of Mn using an array of behavioural tests. 
3) Optimize the Mn application procedure to reduce neurotoxic effects. 
4) Apply MEMRI to a filial generation of stressed rats using subcutaneously 
implanted osmotic pumps for systemic Mn administration. 
5) Compare the resolution of MEMRI recordings to histology in experiments using 
systemic and intraventricular injections. 
 
The present thesis is structured into three chapters. Chapter 2 assesses the intraventricular 
cannulation of Mn and Chapter 3 assesses the use of MEMRI as a tool to analyze 
prenatally stressed rats. The experimental chapters are followed by a final discussion and 
conclusions chapter.   
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CHAPTER 2 
Experiment 1: Intracerebroventricular Infusion of Manganese via Osmotic Pump 
2.1 Abstract  
Toxic effects due to high doses of Mn may confound behavioural and 
morphological investigations in studies using MEMRI. In this study a method of 
manganese administration via an osmotic pump connected to a focal cannula was used. 
These methods were combined in order to reduce the neurotoxic effects of Mn. The result 
of this study demonstrates the successful application of the intracerbroventricular cannula 
and osmotic pump system to administer Mn to the rat brain. Results indicate that a 
concentration of 0.85 mM delivered over 7 days is sufficient to produce MRI-detectable 
levels of Mn, similar to high systemic doses, without causing adverse toxic effects. From 
my knowledge, this is the first approach using an osmotic pump for Mn delivery to the 
lateral ventricles for acquisition of anatomical images using MEMRI. 
 
2.2 Introduction  
Since the late 1990’s when Lin and Koretsky (1997) first introduced the technique 
of MEMRI, numerous studies have used and modified this technique. In spite of the 
recent increase in the number of MEMRI studies, there is no consistent method to 
administer Mn. Researchers use varying concentrations and different methods of 
administration. Inconsistent use of methods complicates the ability to compare results. 
More specifically, there is little consensus among investigators on safe Mn usage in 
animals and Mn concentrations varies between studies (Eschenko et al., 2010a). The 
correct administration of MEMRI requires the development of a protocol that minimizes 
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toxic effects of Mn (Canals et al., 2008). This is especially important when the scientific 
question relies on behavioural analysis. Investigators need to ensure that any deficiencies 
or abnormalities that they see in behaviour are not caused by Mn toxicity.  
  Various strategies have been used to reduce the toxic effects of Mn. The first 
being a focal injection directly to the target or area of interest in the rat brain to reduce 
the amount of Mn required (Silva and Bock, 2008). The second strategy is the use of an 
osmotic pump to slowly increase the concentration of Mn delivered to the rat brain 
(Eschenko et al., 2010a).  
 
2.2.1 Focal Injection to the Lateral Ventricle 
Recent studies have shown that focal injections are beneficial as the issue of 
toxicity is less severe (Silva and Bock, 2008). The benefit of using a direct injection to 
the target area (brain) is two-fold. First, the Mn bypasses the systemic system and 
therefore causes fewer complications (e.g., toxicity in heart, liver, kidneys). Second, a 
lower concentration is sufficient to enhance MRI signal in target regions. The 
intracerebroventricular infusion of Mn is one of several useful focal injection techniques 
employed to minimize the dosage of Mn. The infusion of Mn to combine with the 
cerebrospinal fluid (CSF) allows transfer to the interstitial space of the brain through the 
ependymal layer that covers the surface of the ventricle. Thus, a higher Mn uptake in the 
brain structures adjacent to the ventricles is achieved (Bock et al., 2008, Seo et al., 
2011b). The diffusion of  Mn through the brain tissue and active anterograde transport of 
Mn along pathways enables a focal injection technique, more commonly used for tract 
tracing, to become an application for the visualization of brain anatomy and high 
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resolution mapping in areas such as the hippocampus, pituitary and the basal ganglia, 
which can be comparable to systemic techniques. 
 
2.2.2 Osmotic Pump  
Another way to decrease Mn toxicity while keeping MRI-detectable levels of the 
ion is to avoid acute accumulation of high Mn concentrations by slowly infusing larger 
volumes using osmotic pumps (Canals et al., 2008, Sepulveda et al., 2012).  In contrast to 
a single systemic injection, Mn administration via osmotic pumps allows a reduction in 
acute toxic effects, while achieving cumulative concentrations of Mn sufficient for MRI-
detection (Eschenko et al., 2010a).   
Combining these two techniques, an intracerebroventricular cannula attached to 
an osmotic pump, allows usage of an ample Mn concentration while reducing the toxic 
effects from systemic administration and those seen after bolus injections. The 
behavioural concerns of administering Mn via osmotic pumps has only recently been 
investigated (Eschenko et al., 2010a). This study administered Mn via an IP pump and 
found no effect in running wheel behaviour. To my knowledge, however, behavioural 
consequences of Mn infusion have not been studied when using a pump for focal 
administration to the lateral ventricles.  
 
2.2.3 Objectives  
This study investigates two methods of reducing Mn toxicity while comparing the 
effects of high and low doses. This experiment had four objectives. 
1) Establishment of an MEMRI protocol in rats for direct injection of Mn into the 
lateral ventricle using a cannula and osmotic pump system; 
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2) Compare a high dose, long duration to a low dose, short duration administration; 
3) Optimize the Mn application procedure to reduce toxic effects; 
4) Assess the toxicity of Mn with the use of a behavioural test and histological 
inspection of the respective brain tissue. 
 
 
2.3 Materials and Methods  
2.3.1 Subjects and Housing  
 Four Long-Evans female rats (160 days old and weighing 350-500g) raised at the 
University of Lethbridge vivarium were used in this study. The animals were housed in 
pairs under a 12 hr light/day cycle with lights on at 7:30 AM. Animals had access to food 
and water ad libitum, except during the single pellet reaching task, in which animals were 
placed on a restricted diet while maintaining 85% of their baseline body weight. All 
procedures were performed in accordance with the guidelines of the Canadian Council 
for Animal Care at the University of Lethbridge. 
 
2.3.2 Treatment  
Bicine buffered Mn or bicine as a control was delivered via an osmotic pump 
(ALZET, California). Bicine was used instead of other buffers because it causes less 
toxicity issues (Seo et al., 2011a).  Table 2.1 summarizes the treatment administered to 
each rat. 
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*flux rate is defined as the amount or flow of Mn per unit time  
 
2.3.3 Surgical Procedures 
The rats were anesthetized with 5% isoflurane gas in oxygen flowing at 2 l/min. 
When deeply anesthetized (showing no reflex to a pinch of the toe) the isoflurane gas was 
decreased to 2%. Breathing of the animal was monitored throughout the length of the 
surgery. The rats were injected with 0.03 mg/kg buprenorphine (Shering-Plough, CAN) 
prior to making the first incision. The incision site was also injected with 0.1 ml of 2% 
lidocaine and epinephrine solution (Bimeda-MTC, CAN) to reduce bleeding and 
maintain analgesia. Left or right lateral ventricle (depending on handedness, i.e. left 
handed, cannula was inserted into left hemisphere) was the target for the intracranial 
cannulation. Coordinates were ±2.7 mm lateral, -1.72 mm bregma and 3.7 mm ventral to 
skull surface. After the cannula was fixed to the skull, polyethylene tubing was connected 
from the cannula to the osmotic pump and was the osmotic pump was then inserted 
subcutaneously. Polyethylene tubing was filled with sterile saline so that Mn was not 
administered until after the recovery period.     
It should be noted that two different methods of fixing the cannula to the skull 
were used. Rat 150 was treated first by Dr. David Euston and alterations were made from 
this surgery by Dr. Bryan Kolb. For rat 150, three nylon screws were used and the 
Rat 
Number 
Solution Pump 
Duration 
Concentration Flux Rate  
#150  Mn 28 days  100mM 0.25 µl/hr 200ul 3.125 µg/hr 
#152 Control 28 days 100mM 0.25 µl/hr 200ul 
#151 Control 7 days 0.85mM 1 µl/hr 200ul 0.10625 µg/hr 
#154 Mn 7 days 0.85mM 1 µl/hr 200ul 
Table 2.1 Solution, concentration, duration and rate of administration for each rat.  
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cannula was fixed to the screws with metabond and dental acrylic. Then the screws were 
covered in a silicone adhesive. For rats 151, 152 and 154 a cannula was inserted and was 
fixed using cyanoacrylate instead of dental acrylic. In this case, sutures closed the 
incision over the cannula and pump.  
Following surgery, the rats were injected with 1mg/kg Metacam (Boehringer 
Ingelheim, CAN) and kept in the surgical suite for 24 hrs for monitoring before being 
returned to their homecage. A 0.5 mg/kg dose of Tribrissen (Shering-Plough, CAN) was 
also administered twice a day for 5 days to prevent infection. Rats were given three days 
to recover prior to behavioural testing and imaging. 
 
2.3.4 Behavioural Testing 
Skilled Reaching Task   
The single pellet reaching task was used to demonstrate the effect of Mn on fine 
motor skills. Animals were placed in a reaching box with a vertical slot in the front wall. 
Animals were trained to reach through the narrow opening to retrieve small 45 mg food 
pellets (BioServ Inc., USA). Pellets were placed individually into an indentation on the 
side contralateral to the preferred limb about 1.5 cm away from the front wall. Analysis 
of skilled reaching movements was performed based on protocols published earlier (Metz 
and Whishaw, 2000). Analysis using a three-point scale to rate fine motor movements 
with a rating scale with 11 movement components and 35 subcategories was conducted 
(see Appendix A). Percent success was calculated as an indication of rat’s reaching 
accuracy. It was calculated as a percent of successful reaches over the total number of 
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pellets given (20). The rodents were pre-trained in the reaching task, injected with Mn, 
and tested 5 days a week until the termination of the pumps. 
 
2.3.5 MR Imaging 
Following recovery from surgery, imaging was performed (Rat 150 & 152 imaged 
on days 5,8,10,13,16,19,23,25& 33 days post-surgery, Rat 151 &154 imaged on days 
2,4,8 &10 days post-surgery). A 4.7 T 330 mm bore Oxford magnet (Oxford, UK) and a 
MR5000 (SMIS, UK) console was used (Figure 2.1). A 2-RF coil system consisting of a 
quadrature birdcage transmit coil (10 cm in diameter, 10 cm in length; Morris 
Instruments, CAN), a custom-built receive-only butterfly coil (2 cm in diameter) and PIN 
diode switching was used. Locator images (SE-TR=700 TE=13 ms 0.2x0.2x1.5 mm) 
were followed by a 7-image saturation recovery (SE-TE=22, TR = 100-4000 ms 
0.39x0.39x1.5 mm) T1 mapping data set. Signal intensity from regions of interest (ROIs) 
were extracted from the T1 images using Analyze 8.1 (BIR, USA) and T1 values were 
calculated using custom- written software using IDL (ITT, USA). 
 
 
 
 
 
 
 
 
 
Figure 2.1: Image displaying A: The 4.7 T 330 mm bore Oxford magnet; and B: the  
apparatus for rat immobilization displaying the custom-built receive-only butterfly coil 
off the head; and C: the coil placed on the rat’s head.  
A B C 
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2.3.6 Histology 
 Rats were euthanized at the end of their pump durations. Rats were injected with 
Euthansol (Merck, CAN) and perfused transcardially with a phosphate buffer solution 
(PBS) followed by a trancardial injection of 4% paraformaldahyde (PFA) both with a 
volume of 200 mL (standard operating procedure).  
Brains were extracted and sectioned coronally using a cryostat (rat #150) or 
microtome (rat #151,152,154) at a thickness of 40µm. Twelve series of sections were 
taken and stored in a 1X PBS solution with a 1:1000 concentration of sodium azide to 
prevent growth of bacteria or fungus. Every 3
rd
 series was mounted on slides (VWR 
international, USA) dipped in 1% Gelatin and 0.2% Chromalum, and then stained with 
cresyl violet (for protocol, see Appendix B). The slides were captured as images using a 
Zeiss Axioimager M1 microscope (Zeiss, Germany). 
 
2.4 Results 
2.4.1 Analysis of T1 Relaxation Rates 
 All statistical computations were done using SPSS 13.0 software (IBM, USA). All 
graphs were created using Origin 5.0 lab freeware (Originlab, USA). T1 measurements 
were taken at the base of the cannula (Figure 2.2). Applications of the 28 day and 7 day 
pumps with Mn show an increase in T1 rate which correlates to the concentration of Mn 
used (Figure 2.3). Rats with the higher Mn concentration (28-day pumps) showed a larger 
change in T1 rate (Figure 2.3). Figure 2.3 A and B shows that the T1 rate in both controls 
was around 0.0007 m s
-1
, which is equivalent to naïve rats receiving no treatment. The 
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28-day Mn treated rat reached a T1 rate of 0.0016 ms
-1
 whereas the 7-day Mn treated rat 
reached a lower rate of 0.001 ms
-1
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Coronal slice of the 28-day Mn subject.  Arrow indicates the area of 
pixel analysis for T1 measurements. 
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Figure 2.3:  Time course of the 1/t1 rate (ms
-1
) of the pixel measurements taken from 
under the cannula for A: 7-day subjects and B: 28-day subjects. *note,  for rat 154 the 
last data point is absent due to technical issues that occurred  with the MRI scanner. 
A
 Table 2.1 Solution, concentration, duration and rate of administration for each rat. Flux rate 
was calculated with the assumption that the rat weighed 350g  
 
B 
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T1 maps were created using non-linear 3-parameter curve fitting (Equation 1.1). 
Figures 2.4A and 2.4B show the T1 rate maps of the 7-day Mn rat compared to the control 
respectively. Figures 2.4C and 2.4D show the T1 rate maps of the 28-day Mn rat 
compared to the control respectively. Both maps demonstrate a clear change in the T1 
values from control to Mn treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
Rat 150 had images of better quality and resolution due to the method of cannula 
fixation used (see section 2.3.3 Surgical Procedures). The cyanoacrylate method (used in 
rats 151, 152 & 154) caused a problem with coil placement resulting in poor image 
resolution. Because the cannula was only held in place with cyanoacrylate (as opposed to 
dental acrylic), it was precarious applying the butterfly coil directly against the rats head. 
This decreased the amount of signal gained in the remaining animals.   
Figure 2.4: T1 rate maps for A: 7 day control B: 7-day Mn C: 28-day control D: 28-day 
Mn. Scale bar is 1/200 → 1/3000 ms.  
A B 
C D 
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2.4.2 Signal Enhancement in Hippocampus  
Signal enhancement in the hippocampus was shown in both the 28-day Mn rat 
and the 7-day Mn rat. Figures 2.5A and 2.5B show the progression of the enhancement in 
the hippocampus in the 28-day and 7-day rat respectively.  Note, on day 2 of Figure 2.5B, 
there is an image artifact due to signal from some silicon glue on the coil which became 
folded into the image from outside the area of interest. Figure 2.6 shows that there was 
movement of Mn to the contralateral side of the brain from the cannula, which can be 
seen in a sagittal image. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Coronal images of progression of enhancement in   A: the high dose experiment, 
images acquired 5,13,16,19,28 and 33 days post- surgery B: low dose 2, 4, 8 days post-
surgery. Red arrow is indicating the hippocampal formation. 
5d 13d 
28d 33d 
16d 
19d 
2d 4d 
A 
B 
8d 
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2.4.3 Rat 150- Lesion  
After 10 days post-surgery, a hypointense region began to appear in the brain of 
the 28-day Mn rat. Figure 2.7 shows the progression of this region over time. This black 
region did not appear in the 28 day control, 7 day Mn or the 7 day control. . Figure 2.7 
indicates that this damage occurs after about 13 days. At approximately 13 days, the 
volume of Mn delivered was roughly 90 µl. 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: A: Sagittal image of the enhancement in the hippocampus contralateral to the 
cannula indicating transport across the midline as shown in B: coronal image of 28 day 
Mn subject.  
 
A B 
Figure 2.7: Coronal images of 28 day Mn showing progression of the lesion (red arrow 
indicates lesion). Images represent days 5,13,19,25 and 28 post-surgery. Tissue damage 
on the first two images in the top left hemisphere is due to the screws implanted during 
surgery.  
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2.4.4 Histology  
Using cresyl violet histology it was confirmed that the black mass observed in the 
28-day Mn rat was a lesion (Figure 2.8C). Figure 2.8 shows the corresponding brain 
slices to the MRI images of rats 150 and 152. In cresyl violet stained histological 
sections, a region of cell loss within the Mn injection site with a length of approximately 
0.67 mm was observed (Figure 2.8D). This result indicates that localized cell death 
occurred near the tip of the cannula. The control experiments did not show significant 
cell damage confirming that the cause was due to the Mn cytotoxicity in the solution.  
 
 
 
2.4.5 Behavioural Observations  
2.4.5.1 Skilled Reaching Task  
Observations in the single pellet reaching task demonstrated that the Mn had no 
effect on the fine motor skills (using student’s t-test, P=0.68 for 28-day and P=0.5 for 7-
day rat) (Figure 2.9). Qualitative analyses also showed that there was no change in fine 
motor skills after Mn infusion.  
 
Figure 2.8: Histological slices (cresyl violet) corresponding to MRI images indicating the 
extent of cell damage. A: 28-day control MRI B: histological slice 28-day control C: 28-
day Mn D: histological slice 28-Day Mn. 
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Figure 2.9:  Percent success (measured as: # of successful reaches/# of total reaches) over reaching 
days of the A: 7 day pump rats and the B: 28 day pump rats. P=0.68 for 28-day and P=0.5 for 7-
day rat. Rats maintained reaching success over the course of Mn treatment. 
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2.4.5.2. Body weight 
 Figure 2.10 shows the average weight of rats pre- and post-surgery. There were 
no significant changes in the body weight during the course of the study.  
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2.5 Discussion 
2.5.1   T1 Relaxation Time Due to Mn Infusion 
The findings of the present study illustrate the successful application of an 
intracerebroventricular cannula and osmotic pump system to administer Mn to the rat 
brain. To my knowledge, this is the first time an osmotic pump was used to deliver Mn to 
the lateral ventricle. Results indicate that a concentration of 0.85 mM delivered over 7 
days, and a concentration of 100 mM delivered over 28 days are both sufficient to 
Figure 2.10: Average weight of rats pre- and post-surgery.  
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produce MRI-detectable Mn levels. A higher T1 rate in Mn-treated rats is expected 
because the rate of T1 relaxation is directly proportional to the Mn concentration (Silva et 
al., 2004). Hence, the higher the Mn concentration, the higher the T1 rate.  
The present findings also indicate that the relaxation rate change due to the 
delivery of Mn plateaus after approximately 20 days when using the 28 day pump. 
Unfortunately, there are no studies which have used a slow release technique (28 days) to 
compare these results to. However, it could be postulated that these findings could be due 
to the cell death caused by relatively high Mn concentration. This may have decreased or 
restricted Mn flow to the surrounding brain tissue as the transport mechanism may have 
been blocked by the dead cells. This result is similar to a study that administered 120 mM 
Mn focally into the medial thalamus (Yang et al., 2011). They also caused a lesion due to 
high concentrations of Mn and found that the subsequent signal enhancement was focal 
with a small deposition of Mn to other areas. Another explanation for the restricted flow 
of Mn to the site of injection could be due to the accumulation of Mn given the high 
density of astroglia and their reaction to the tissue damage (Kawai et al., 2010). Astroglia 
act as metal depots (Tiffany-Castiglioni and Qian, 2001) and one of their roles includes 
the repair and scarring of brain and spinal cord tissue following traumatic injuries. Thus, 
the presence of tissue damage could attract Mn primarily to this area.  
Mn delivery from the 7-day pump peaked on the last day of delivery contrary to 
the 28-day pump which peaked on day 14 (mid-way). This is analogous to bolus systemic 
injections that use higher concentrations or slow release administrations with osmotic 
pumps (Eschenko et al., 2010a). This indicates that using a direct injection to the lateral 
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ventricle could be used alternately to systemic injections. Like systemic injections, 
enhancement is prominent in regions such as the hippocampus (Aoki et al., 2004b).   
 
2.5.2 Enhancement in the Hippocampus 
In the present study, Mn was detectable in the brain and was prominently 
accumulated in the hippocampal region. This result is analogous to other studies that 
showed a movement of Mn from the CSF to brain tissue (Liu et al., 2004, Jeong et al., 
2012). Moreover, these results validate the theory that signal enhancement primarily in 
the hippocampus is caused by Mn absorption from the ventricles (Aoki et al., 2004c, 
Bock et al., 2008). Also, as described in Chapter 1, it has also been shown that the 
distribution of manganese may reflect the density and or activity of astrocytes 
(Henriksson and Tjalve, 2000), neurons (Pautler et al., 1998), or mitochondria (Akai et 
al., 1990, Gavin et al., 1990). It may be a combination of the location and composition of 
the hippocampus which causes it to have high signal intensity due to Mn. 
This noticeable detectability in the hippocampus can allow researchers to take 
advantage of this technique for studies which focus on the anatomy or activity of the 
hippocampus (Lui et al., 2011, Palacios et al., 2011). From the results of this study, it is 
obvious that the higher concentration of Mn shows a larger change in hippocampal 
enhancement whereas the lower concentration has a small change. This suggests that in 
order to achieve large changes in hippocampal enhancement, concentrations higher than 
0.85 mM are necessary. Consequently, increasing the concentration may cause 
hindrances when it comes to studies of behavior. One study has already shown that that 
200 mM/kg Mn produces hippocampal MR signal enhancement without disrupting 
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hippocampus-dependent behavior. They used a rapid place learning task indicating that 
studies could apply behavioural testing while using MEMRI (Jackson et al., 2011). The 
present study also reveals insights into the behavioural significances of Mn toxicity.  
 
2.5.3  Behaviour  
Mn treatment typically results in decreased motor activity or disturbances in 
motor coordination as well as Mn-induced hyperactivity (Eriksson et al., 1987, Calabresi 
et al., 2001). However, this study shows that in all cases, the behaviour was not 
significantly affected by the infusion. This could be explained by the ability of a focal 
intracerebral injection to bypass the systemic system, which reduces the risk of 
complications. Furthermore, a study showed  that the slow administration of Mn over a 
long period of time reduced behavioural deficits seen when using bolus injections 
(Eschenko et al., 2010a). The combination of these two factors; direct injection and slow 
infusion, leads to an appropriate method of reducing Mn-associated neurotoxicity (for 
0.85 mM) and spared behavioural function.   
Also, the present findings show an absence of significant changes in body weight 
during the time-course of Mn administration. This could indicate that the focal injections, 
because they bypass the systemic system, are less stressful to the rat’s health as they are 
able to maintain body weight. 
 
2.5.4 Histology and Lesion 
The evaluation of cresyl violet-stained sections revealed that Mn can be delivered 
without cell damage at a concentration of 0.85 mM and at a rate of 1 µl/hr over 7 days. 
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Inspection of the histological data, however, indicated that administering Mn at a 
concentration of 100 mM with an infusion rate of 0.25 µL/hr over 28 days caused cell 
damage. Findings indicate that a concentration of or exceeding 100 mM was not suitable 
for intracerebral injections. A slow release mechanism using an osmotic pump still did 
not alleviate the neurotoxic effects of 100 mM Mn. These data contradict a recent study 
suggesting that under conditions of continuous infusion, Mn was continuously 
transported away from the infusion site by neurons and detoxified by glial cells, which 
prevented the tissue concentration from reaching a toxic threshold (Canals et al., 2008). 
This might only be the case when the concentration is low enough to prevent the 
formation of reactive glial cells, which attract Mn to areas of brain distress instead of 
being removed from the infusion site.  
Another interesting finding was based on a comparison of lesion sites between 
studies. The data is comparable to images obtained by Seo et al. (2011). Although these 
authors showed similar MRI results, their “lesion” was attributed to a different cause than 
neurotoxicity. In their study they administered a concentration of 2 mM Mn-bicine at 50 
µl/ hr  and stated that the “dark mass” which appeared was simply an artifact in the left 
ventricle of the image (Seo et al., 2011). They attributed the hypointense region of 
interest to a high concentration of Mn or high intensity due to Mn. This is a possibility as 
these authors used a microinjection of a smaller concentration.  However, without 
histological evaluation, it is impossible to confirm the mass as an image artifact and not a 
lesion. This result enforces the importance of histology when developing MEMRI 
applications.  
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2.6 Conclusion  
Many studies have explored the route of Mn injections, toxicity of injection dose, 
sensitivity to anatomical structure analysis and changes in signal intensity over a time 
course after injection. However, there is no consistent method for the administration of 
Mn, even when comparing between studies with a similar method of administration. The 
efficacy of MEMRI could benefit from the development of consistent methodologies for 
each type of administration and purpose. However, studies of various models are needed 
to better analyze the different injection routes of Mn and the optimal doses before a 
consistent procedure is created.  
 In this study, a method for the application of Mn to the lateral ventricle was used. 
It was shown that a low dose delivery of Mn at 0.85 mM, using a 7-day osmotic pump, 
showed detectable changes in MRI without causing adverse toxic effects. The importance 
of behavioural testing and histology was demonstrated by the findings that the application 
of a high Mn concentration at 100 mM over 28 days causes severe cell damage at the tip 
of the cannula.  
 
Future Studies 
This project represented a pilot investigation of a high and low dose application of 
Mn for MEMRI. Observations suggest that a comparison of medium-dose Mn 
concentrations is necessary to evaluate the range of Mn-induced effects on toxicity and 
imaging parameters. Histology and behavioural tests should be applied to assist in 
determining the boundaries of the applications of MEMRI. Further work is needed in 
these areas and technical issues must be considered. An experiment using 2 mM Mn 
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delivered over 7 days is in the planning stages. Also a solenoid surface coil which has an 
open area in the center to prevent contact with the cannula is being fabricated. With these 
improvements, MEMRI will prove to be an extremely useful imaging tool for structural 
and functional analysis in neuroscientific studies.  
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CHAPTER 3 
Experiment 2: Application of MEMRI- F3 Generation Stress and MEMRI  
3.1 Abstract 
Prenatal stress has been proven to cause abnormal neuroanatomical, cognitive, 
behavioral and psychosocial outcomes in both humans and animals. The consequences of 
prenatal stress across generations of animals on these outcomes, however, have not been 
studied in detail. This study is the first to investigate the effect of transgenerational 
prenatal stress (TPS) on brain morphology in rats using MEMRI and histology. The 
results revealed that the experience of prenatal stress across three generations results in a 
3% reduction in hippocampal volume and a 7 % reduction in whole brain volume. The 
percent volume of hippocampus in relation to whole brain volume, however, was not 
different in TPS rats versus control rats. This observation may indicate that the 
hippocampal volume changed as a function of whole brain volume. Additionally, this 
study investigated the use of a subcutaneous osmotic pump to deliver Mn for MEMRI. 
When Mn, is released slowly with the use of an osmotic pump, all rats showed a visible 
reduction in T1-relaxation in the hippocampus. These findings indicate that MEMRI 
represents a valid tool for the study of stress-induced changes in brain development. 
 
3.2 Introduction 
3.2.1 Prenatal and Transgenerational Stress 
The perinatal period is a critical period for the development of the brain. As such, 
it is a very susceptible period for environmental and physiological factors, such as stress, 
to disturb homeostasis and development (Ruiz et al., 2005). The term stress is used to 
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describe any physical or psychological challenge that threatens, or has the potential to 
threaten the natural regulatory capacity of an organism (Koolhaas et al., 2011). 
Pregnancy and early development in the offspring represent a particularly vulnerable 
period to respond to environmental stressors. A recent cross sectional study found that 
6% of pregnant women reported high levels of psychological stress, such as depression, 
panic disorder, or domestic violence, during their pregnancies, and 78% reported low to 
moderate levels (Woods et al., 2009).    
The experience of stress by the pregnant mother activates the hypothalamic-
pituitary-adrenal (HPA) axis to initiate the release of stress hormones, such as cortisol in 
humans or corticosterone in rats, which may enter the fetal circulation (Migeon et al., 
1956, Takahashi et al., 1997, Williams et al., 1999). Thus, chronic stress may cause 
prolonged elevation in plasma cortisol in both the maternal and fetal circulation 
(Takahashi et al., 1998). Prenatally stressed offspring have been shown to exhibit 
heightened sensitivity to stress-induced HPA hormone secretion (Fride et al., 1986, 
Henry et al., 1994, Takahashi et al., 1988). 
Studies demonstrated that a variety of different stress models in mice, rats and 
primates causes anatomical differences in brain regions such as the hippocampus as well 
as the prefrontal cortex (Palacios et al., 2011, Golub et al., 2011). More specifically, 
prenatal stress can cause negative effects on the hippocampal formation of offspring. 
These effects include inhibition of neurogenesis, reduction in hippocampal volume and 
resulting behavioural deficits in spatial memory  (Zhu et al, 2004, Lemaire et al., 2000, 
Lucassen et al., 2009, Lui et al., 2011, Coe et al., 2003).   
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The hippocampal pyramidal neurons contain a high concentration of 
glucocorticoid receptors that are sensitive either to hypercortisolemia caused by severe 
stress or to exposure to exogenous glucocorticoids (McEwen, 2000). Work in an animal 
model showed that when exposed to high and/or long-term doses of corticosteroids or 
intensive stress, individuals suffered from structural and behavioural changes and often 
hippocampal neuronal death (Zach et al., 2010, Crews et al., 2012).  
Given that most previous conclusions from animal studies are based on ex-vivo 
findings, this study aimed to assess consequences of TPS on the rat brain using MEMRI 
and comparisons to histology. 
 
3.2.2 Application of MEMRI  
3.2.2.1 Structure 
Recently, the first MRI study on prenatal stress effects in animals was conducted, 
which revealed gross hippocampus pathology in prenatally stressed adult rats (Lui et al., 
2011). Prior to this study, animal structural MRI has been used to show that chronic 
stress (chronic restraint, 6 hrs per day for 21 days) can reduce the overall size of the 
hippocampus (Lee et al., 2009). MRI was also able to report an approximate 3% decrease 
in hippocampal volume following chronic stress (Lee et al., 2009).  
MEMRI is particularly suitable for longitudinal studies in rodent models of 
disorders in which hippocampal dysfunction has been implicated (Jackson et al., 2011). 
As shown in the previous chapter, Mn-induced signal enhancement is highly 
heterogenous across the brain, with some structures, including the hippocampus, showing 
particularly pronounced enhancement (Chapter 2). Recently, a study used MEMRI to 
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assess long-term consequences of post-traumatic stress disorder of hippocampal volume 
in mice (Golub et al., 2011). Using MEMRI, the authors were able to report a reduction 
in hippocampal size. 
 
3.2.2.2 Uptake time 
The technique of MEMRI is a unique tool to show not only vivid structural 
abnormalities, but also brain activation changes (due to uptake through Ca
2+
 channels) or 
uptake time of Mn (rate at which Mn is transported through the brain) in association with 
the metabolic response to stress (Cortez et al., 2008). Studies have used MEMRI to 
demonstrate that manipulations in mice significantly reduce signal intensity in multiple 
brain areas of fasted compared to ad libitum fed mice (Hankir et al., 2011, Kuo et al., 
2005, Parkinson et al., 2009 and Chaudhri et al., 2006). Stress has been proven to have an 
effect on metabolism in human and animal studies. Therefore the uptake time of Mn 
between stressed and control groups will be investigated. Many, but not all, stressful 
events are accompanied by global increases in cerebral blood flow and/or energy 
metabolism (Byran et al., 1990). It may be possible to detect these changes with MEMRI, 
which represented the main aim of this experiment.  
 
3.2.3 Objectives  
For this study, great-grand-offspring (F3) generation stressed adult Long-Evans 
rats were compared to non-stressed rats using MEMRI with the delivery of MnCl2 using a 
subcutaneously implanted osmotic pump. The hypothesis was that the stress effect from 
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the parental generations will be transferred to the F3 filial generation (Zucchi et al., 
2012). 
 
For this study, the aims were to: 
1) Study changes in structure (whole brain and hippocampal),  
2) Explore differences in uptake time (of MnCl2) and, 
3) Investigate differences in contrast (higher vs lower T1 due to the amount of Mn 
present in a set region). 
 
Based on the current literature, to my knowledge, there is no model of 
transgenerational stress that has documented changes in brain morphology using MEMRI 
or histology. 
 
3.3 Materials and Methods 
3.3.1 Transgenerationally Stressed Rats 
 
 
 
 
  
 
 
Figure 3.1: Schematic diagram representing gestational stress across generations and the 
offspring which were used in this study. Representation of Parental generation (F0), offspring 
(F1), grand-offspring (F2) and great-grand-offspring (F3) are shown here.  
 
 
F0 F1 F2 F3 
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In order to obtain F3 transgenerational stressed rats, three generations of pregnant 
dams were stressed using restraint (Morley-Fletcher et al., 2003) and forced swimming 
(Porsolt et al., 1978) from gestational day 12 to 18. Stressors were given at semi-random 
alternations in the morning or afternoon. For restraint stress, animals were placed in 
restraint containers for 20 minutes daily. For swim stress, the animals were placed in a 
pool containing lukewarm water for 5 minutes. 
 
3.3.2 Subjects and Housing  
 Twelve multigenerationally stressed F3 and six non-stressed F3 control female 
Long-Evans rats raised at the University of Lethbridge vivarium were used in this study. 
The animals were housed in pairs or triplets under a 12 hr light/day cycle with lights on at 
7:30 AM. All subjects had access to food and water ad libitum. All procedures were 
performed in accordance with the guidelines of the Canadian Council for Animal Care at 
the University of Lethbridge.  
 
3.3.3 Treatment  
 Eighteen Long-Evan female rats (90 days old and weighing 340 ± 35 g) were 
divided into two groups; multigenerationally stressed (n =12) and controls (n=6). Each rat 
was implanted with a 7-day ALZET osmotic pump with a concentration of 100 mM at an 
infusion rate of 1 µl/hr with a total volume of 200 µl. Based on the weight of the rat, the 
total dose delivered was approximately 7.14mg/kg. In all cases, the solution was pH-
adjusted to 7.4 using NaOH and TRIS-HCL buffer.  
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3.3.4 Surgical Procedures  
Rats were anesthetized according to the procedure outlined in Chapter 2. A small 
incision was made between the shoulder blades of the rat and a pocket under the skin was 
made using hemostats. The pump was inserted into the pocket and the incision closed 
with sutures. The contents of the pump were delivered into the local subcutaneous space. 
Absorption of the compound by local capillaries resulted in systemic administration. This 
lead to an indirect supply of MnCl2 to the brain through the BCB. The osmotic pump 
allowed for continuous delivery of MnCl2 over time. 
 
3.3.5 MR Imaging 
Imaging was performed using a 4.7 T 330 mm bore Oxford magnet (Oxford, UK) 
and a MR6000 (MR Solutions, UK) console. A 2-RF coil system consisting of a 
quadrature birdcage transmit coil (10cm in diameter, 10 cm in length, Morris 
Instruments, CAN), a homebuilt receive only butterfly coil (2 cm in diameter) and PIN 
diode switching was used. Control images were taken as baseline images prior to surgery. 
Following recovery, imaging took place every second day. The imaging protocol 
consisted of: a) Locator images (SE-TR/TE 700/13 ms, 0.2x0.2x1.5 mm), b) T1-weighted 
images (TE 15ms, TR=700 ms, 0.23x0.23x2 mm) c) T2-weighted images (TE=75 ms, 
TR=3000 ms, 0.23x0.23x2 mm) d) T1 measurements (TE=10 ms, TR=6000 ms, 
0.47x0.47x2 mm) e) T2 measurements (TE=30,60,90 ms TR=2500 ms, 0.47x0.47x2 
mm).  
Signal intensity from regions of interest (ROI’s) were extracted from the T1 
images with Analyze 8.1 (BIR, USA) and T1 values were calculated using home written 
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software in IDL (ITT, USA). All images were co-registered (Figure 3.2A) and in some 
cases, the two sets of T2-weighted images were added together to obtain a higher signal-
to-noise ratio (Figure 3.2B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.6 Histology 
 Rats were euthanized at the end of their pump duration (10 days post-surgery) 
with an injection of Euthansol (Merck, CAN). They were then perfused transcardially 
with PBS followed by a trancardial injection of 4% PFA both with a volume of 200 mL. 
Figure 3.2: A) Analyze 8.1 co-registration showing a match image fused to a base T2-
weighted coronal image. B) Image calculator, combining two T2-weighted images. 
A B 
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Brains were extracted and were then sectioned and sliced coronally using a microtome at 
a thickness of 40 µm. Twelve series were taken and stored in a 1X PBS with a 1:1000 
concentration of sodium azide to prevent growth of bacteria or fungus. Every 3
rd
 series 
was then mounted and stained with cresyl violet (for protocol, see Appendix B).  The 
slides were captured using a Zeiss Axioimager M1 microscope (Zeiss, Germany) at 1X 
magnification (Figure 3.3).  
 
 
 
 
 
 
 
 
 
3.3.7  Volumetric Measures  
3.3.7.1 MEMRI 
A traced contour of the whole brain was manually drawn on each of the seven 
slices from T1 and T2-weighted images on the control and last day of Mn delivery, using 
Analyze 8.1 (BIR, USA). The hippocampal volume was manually traced and was 
calculated with 2 slices corresponding approximately -2.12 mm and -5.5 mm from 
bregma. Measurement boundaries were defined according to Wolf et al. (Wolf et al., 
2002) and by referring to the rat atlas of the brain (Paxinos and Watson, 1998).  
Figure 3.3: Examples of cresyl violet histology. Coronal sections taken through the 
hippocampus of are displayed here.  
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Histology 
 
3.3.7.2 Histology 
The volumetric measurements of the hippocampus were made on all but one 
structure within the hippocampal formation. Included were the subfields CA1-CA3 and 
the dentate gyrus of the hippocampus. Excluded was the entorhinal cortex (EC) because 
the precise boundary between the EC and the rest of the cortex was not clearly defined 
through the Nissl staining. Measurement boundaries were defined as reported previously 
(Verstynen et al., 2001).  
The relevant hippocampal areas were determined according to the stereotaxic 
atlas of the rat brain (Paxinos and Watson, 1998) and measured using Image J analysis 
package (NIH, USA) for PC. The volume of each hippocampus was calculated as the sum 
of the product between the area on each slice and the inter-slice distance. In case a slice 
was missing or damaged the area was estimated by taking the average of the areas from 
the slices immediately posterior and anterior to the missing slice. Averaging was 
necessary for approximately 4-7 slices for each rat.   
 
 
 
 
 
 
Figure 3.4: The whole brain ROI is shown to the right in red. The left (red) and right 
(green) hippocampal ROI’s are shown to the left.  
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3.4 Results  
 
3.4.1 Analysis of T1 Relaxation Rates 
 
 All statistical computations were performed using SPSS 13.0 software (IBM, 
USA). All graphs were created using Origin 5.0 lab freeware (Originlab, USA). Results 
show that Mn was transferred to the brain using the systemic application of the osmotic 
pump. Figure 3.5 shows that the concentration used was not sufficient to produce large 
changes in T1 relaxation times, however, they were significant (using student’s t-test, 
n=18, p=0.007). Consequently, there was no significant difference (p=0.274) in uptake 
time between the stressed groups and the control group. Figure 3.6 shows the increase in 
hippocampal signal from control to day 8 of Mn administration. 
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Figure 3.5: T1- rate (ms
-1
) taken using the average whole brain ROI. Error bars represent 
the standard error of the mean (SEM). Control (n=6) TPS (n=12). 
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Figure 3.6: Coronal images of 2 slices corresponding to -2.3 and -4.5mm from bregma. 
Increasing in signal enhancement is shown as an increase in manganese concentration of 
days post-surgery.   
Control 
Day 2 Mn 
Day 4 Mn 
Day 6 Mn 
Day 8 Mn 
-4.5 Bregma       -2.3 Bregma 
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3.4.2 Volumetric Analysis  
 
3.4.2.1 MRI 
 
  
 From the whole brain ROI’s drawn on the T1 and T2-weighted MRI images, the 
results as shown in Figure 3.7 were obtained. On average, stressed rats had whole brain 
volumes which were 7% smaller than controls (p=0.002). There was no significant 
change in volume between the control and last day of Mn delivery images. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 Animals in the TPS group showed a 15% reduction in hippocampal volume 
(Figure 3.7).  These results were found to be significant (p<0.001). There was some 
difficulty drawing ROI’s on the hippocampus of the T1 and T2-weighted images. In some 
cases T1 images were easier to trace ROIs and in other cases it was easier to trace on T2 
images. Therefore an average of T1-weighted and T2-weighted ROI’s were used.  
Figure 3.7: Volume (mm
3
) of the whole brain MRI showing a reduction in TPS 
volume. Error bars represent the SEM. *p<0.05.   
TPS 
CONTROL 
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3.4.2.2 Histology  
  When comparing the average hippocampal volumes of TPS rats to control rats, 
there was a 3% reduction in volume. These values were found to be significant 
(p=0.009). However, hippocampal volumes relative to the whole brain volumes were 
found to be equally distributed between the TPS group and the control group (Figure 3.9).  
For percent difference, hippocampal ROI’s from histological slices and whole brain 
MRI’s were used. A correlation between a whole MRI slice and corresponding histology 
slice was made and found to be relatively similar (±0.9mm
2
). 
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) of the hippocampus from MRI images showing a decrease 
in TPS volume. Error bars represent the SEM **p<0.001. 
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Figure 3.9: Volume (mm
3
) of the hippocampus from Nissl stained slices. Error bars 
represent the SEM  * p<0.05. 
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3.4.2.3 Weight Change  
The change in body weight was calculated by subtracting the one-week average 
body weight prior to pump implantation. Weight loss within these rats was variable and 
there was no significance (p>0.05) between TPS and control groups. On average, rats lost 
around 8 ± 7g of body weight with the highest weight loss of being 20g.    
 
3.5 Discussion 
3.5.1 Relaxation Time due to Mn 
In this study, F3 TPS rats were compared to non-stress control rats using MEMRI 
and histology. Investigated was brain structure (primarily changes in hippocampal 
volume) and differences in uptake time of Mn from F3 generation stressed rats compared 
to controls. 
 Results indicate that the concentration of Mn used was not high enough to detect 
changes in uptake time of Mn between TPS and control rats. Figure 3.6 shows an 
increasing trend in Mn concentration in both the TPS group and the control group. 
Comparing F3 TPS rats to control rats, the TPS rats have a higher Mn concentration than 
control rats, but these results were not significant. Further study is required to answer this 
question. Results could be clearer if a higher concentration of Mn was used. This could 
be achieved with a larger osmotic pump, to be discussed in chapter 4.   
Nevertheless, with the concentration used, there was an increased enhancement in 
the hippocampus in the T1-weighted images. Both the T1 and T2-weighted images for 
ROI assessment of the whole brain and the hippocampal volumes were used. From the 
ROI’s drawn, it was determined that the average whole brain volume of the TPS rats was 
64 
 
reduced by approximately 7% compared to control rats. Also, it was found that the 
hippocampal volume was decreased by approximately 15%. However, from the ROI’s 
drawn on the histological slices, more precise measurements of hippocampal volume 
were obtained compared to those obtained from MRI. It was found that the TPS rat’s 
hippocampus is on average 3% smaller than the control rat.   
These results suggest three reasons why there was a difference in volumes 
obtained in MRI versus histology. The first is that from the resolution obtained, it was 
difficult to determine the hippocampal boundaries on MRI as the contrast to noise was 
low. Also, the resolution obtained with the control images (taken a month after 
assessment of the TPS rats) was of better quality due to internal or external variable noise 
beyond my control. Second, the SNR differed from day to day which caused 
inconsistencies in assessment. Lastly, it is easier to draw ROI’s on the stained slices as 
the spatial resolution is higher. Histology has proven to be a more reliable method for 
determining volumes in this study. This is because of the higher resolution obtained as 
well as the number of slices which were used to calculate volume with histology (approx. 
95 slices) compared to MRI (7 slices). This does not take away the advantage of the use 
of MRI in longitudinal studies when ex-vivo measurements are not possible. Also, 
MEMRI at higher concentrations has recently been shown to provide images of higher 
resolution that are comparable to histology (Shan et al., 2012). These issues concerning 
MRI and Mn concentrations will further be discussed in chapter 4.  
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3.5.2 Volumetric Analysis 
There are no studies conducted on the effects of prenatal stress across 3 
generations to compare to the current study. Therefore the comparisons were among F3 
TPS stress to stress across one generation or chronic stress in general. There are only a 
few studies that analyzed volumetric measurements in prenatally stressed animals. A 3% 
reduction in hippocampal brain volume of stressed rats was found. Only one other study 
of volumetric measurements was performed in rodents. After subjecting pregnant dams to 
restraint stress their study showed that hippocampal wet weights of 3-month-old 
offspring were reduced by 15.4% in PS males and by 8.2% in PS females (Szuran et al., 
1994). Also, studies have been performed in non-human primates. One study investigated 
hippocampal volume in rhesus monkeys and found a 10-12% reduction in the 
hippocampus (Coe et al., 2003) using ex vivo measurements, whereas another group 
found a 30% reduction (Uno et al., 1994). These reductions in hippocampal volumes are 
much greater than the reduction found in this study. The effects may be more similar to 
rats exposed to chronic stress as the present results are more comparable to a study which 
found a 3% reduction in rats exposed to chronic stress (Lee et al., 2009). One explanation 
is the type of stressor used. All of the studies above differ in the timing of exposure to the 
stressor and type of stressor. These parameters have different effects on the HPA axis 
response in pregnant dams and may determine the effects of PS on brain development. 
The present approach cannot directly address the underlying cellular mechanisms 
by which stress reduces the size of the hippocampus. The major theory in the field states 
that stress-related hypercortisolemia causes hippocampal atrophy (McEwen, 2000). The 
present findings are consistent with earlier reports of apoptosis, dendritic atrophy and a 
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decrease of neurogenesis associated with PS (Zhu et al., 2004, Lemaire et al., 2000, 
Gould et al., 1997). The present results are also consistent with findings that epigenetic 
imprints of environmental stress may persist through multiple generations (Zucchi et al., 
2012).  
Since the choice of brain regions studied is driven by previous anatomical, 
behavioral and cognitive findings on the effects of PS in the offspring, there might 
possibly exist other regions that are equally affected by PS or TPS (Charil et al., 2010). 
For this reason, a whole brain volumetric measurement was taken as well. A 7% 
reduction in whole brain volume was found. The percent difference of hippocampus to 
whole brain volumes did not change in TPS rats compared to control rats. This could 
indicate that the hippocampal volume changed as a function of whole brain volume. 
Many of the studies above did not include whole brain volume and relative differences. It 
is, therefore, impossible to compare the present hippocampal results with these studies. 
There is some research which suggests that stress could cause a reduction in whole brain 
volume, and not just the major areas of interest; hippocampus, amygdala and prefrontal 
cortex. One study found that PS reduced the number of immature microglia (Gomez-
Gonzalez et al., 2010). During early development of the central nervous system, 
microglial cells exert multiple protective and organizational functions that are necessary 
for proper neural development (Kaur et al., 2007). The mechanisms underlying these 
volume reductions are largely unclear. 
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3.6 Conclusions 
 Taken together, this study showed that the brain volume of animals that are 
multigenerationally stressed was negatively affected. The results validate the hypothesis 
that the parental stress effect is transferred to the filial generation and their progeny. A 
3% reduction in hippocampal volume and a 7% reduction in whole brain volume 
compared to controls were found. MRI findings differed from histological measurements 
in number but not direction of change. To my knowledge, this is the first study which has 
shown volume reduction in rat brains of generationally stressed rats with the use of MRI. 
Also shown was an application of MEMRI and also included were some suggestions to 
improve the application. When Mn is released slowly with the use of an osmotic pump, 
there is a visible reduction in T1-relaxation in the hippocampus. A general discussion on 
technical difficulties and considerations from this study will be provided in Chapter 4.  
 
Future Studies  
For future studies, it would be very interesting to see if a higher concentration of 
Mn could show differences in brain activity between TPS rats or stressed rats in general 
compared to controls. Also, there have been many reports of changes in stress response 
between male and females. It would be interesting to investigate these changes using 
MEMRI. Another interesting study would be to compare brain volumes from F1-F3 
generations. Additionally, studies on methods of reversing neurobiological effects of 
stress would also be interesting and the use of MEMRI would be a great addition to these 
longitudinal studies. As you can see, there are many promising opportunities for further 
research in this area. 
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CHAPTER 4 
 
General Conclusions on the use of MEMRI in Neuroscience 
 
 
4.1  Summary 
 
The main objective of this  research was to apply MEMRI to studies in 
Neuroscience by first establishing the limitations concerning the use of MEMRI in live 
rats. In Chapter 2, a MEMRI protocol in rats for direct infusion of Mn into the lateral 
ventricle using a cannula and an implanted osmotic pump system was introduced. The 
neurotoxicity of Mn using single pellet reaching was analyzed. Optimization of the Mn 
application procedure to reduce neurotoxic effects by comparing the effects of a low and 
a high dose. In Chapter 3, MEMRI was applied to a filial generation of stressed rats using 
subcutaneously implanted osmotic pumps for systemic Mn administration. In both 
chapters, images obtained using the MEMRI technique were compared to histology. 
 As described in the previous chapters, MEMRI has vast applications in 
Neuroscience. Its abilities to detect brain anatomy were displayed in Chapter 2 and 
Chapter 3. Chapter 2 utilized a method for the application of Mn to the lateral ventricle. It 
was shown that a low dose delivery using a 7-day osmotic pump shows Mn detectable 
changes in MRI without causing adverse toxic effects. To my knowledge, this was the 
first MEMRI experiment in which Mn was slowly infused into the lateral ventricles. 
Chapter 3 showed that the brain volume of transgenerationally stressed animals is 
negatively affected. Using MEMRI and histology, a 3% reduction in hippocampal 
volume and a 7% reduction in whole brain volume was found. MRI findings differed 
from histological measurements in number but not direction of change. To my 
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knowledge, this was the first study which has shown volume reduction in the brains of 
generationally stressed rats using MEMRI. 
 Because it is relatively noninvasive, MEMRI allows for repeated or longitudinal 
studies to follow the progression of disease or changes in anatomy.  Results from Chapter 
3 showed that MEMRI has abilities in increasing signal intensity to visualize 
cytoarchitecture. Histological methodologies are predominantly applied for the analysis 
of structural changes. However, these methods are limited by numerous factors including 
the examination of pre-selected brain regions, tissue alteration by the fixation method, 
depiction of neuroanatomical structures at one distinct time point per animal, and the 
sheer effort needed to examine all areas of the brain. MEMRI has abilities to not only 
detect brain anatomy but also track changes over time, which has caused MEMRI to 
become one of the leading techniques in MRI. MEMRI at higher Mn concentrations and 
at higher MR field has been shown to provide images of higher resolutions that are 
comparable to histology (Bridge et al., 2006, Shan et al., 2012). 
 MEMRI not only allows structural research but also identification of activation 
differences of certain brain areas. Numerous studies have shown that systemic 
administration of MnCl2 leads to an activation-dependent accumulation of Mn. In 
Chapter 3, the visualization of changes in activation between the control rats compared to 
the TPS rats was attempted. Unfortunately, the concentration used in this study was not 
high enough to show significant changes. The limitations of the osmotic pump which led 
to this low concentration used will be discussed below. 
 The experiments provided some of the basic tools and validation procedures 
necessary for broader applications of MEMRI in studies with rats. Through these studies 
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the abilities/disabilities of MEMRI in terms of delivery method, toxicity and technical 
considerations were demonstrated. 
 
4.2  Methods of MEMRI 
4.2.1 Systemic versus Direct Administration of Manganese 
 Many studies have explored the route of Mn injections, toxicity of injection dose, 
sensitivity to anatomical structure analysis and changes in signal intensity according to 
the time-course after injection. However, there is no consistent method for the 
administration of Mn. When choosing a method of administration, most researchers will 
base their decision on the type of study that they wish to conduct and the ease and 
efficiency of the delivery method. In the present study, two different methods were 
applied (SQ osmotic pump and continuous delivery using focal cannula), both of which 
were used to show whole brain anatomy in areas where Mn would be transported. 
In Chapter 2, it was shown that a low dose delivery of 0.85 mM Mn to the lateral 
ventricles, using a 7 day osmotic pump, induces detectable changes in MRI without 
causing adverse toxic effects. Work in Chapter 2 showed that a concentration of 100 mM 
Mn delivered over 28 days is too high for a direct cannulation while 0.85 mM delivered 
over 7 days is too low. There are only two other studies which have used focal injections 
into the CSF to show whole brain anatomy (Liu et al., 2004, Jeong et al., 2012). Jeong et 
al. (2012) used a 20 mM concentration into the region of the cisterna magna. Their results 
suggest that 20 mM of MnCl2 in a volume of 50 µl is a physiologically stable dose for 
ICV administration in the rat and provides an optimal image for structural analysis of a 
75 
 
rat brain 24 h after administration. However, in this study, it was not determined if 
behavior was affected. This will be vital for future studies.  
In Chapter 3, Mn was released slowly with the use of a systemically implanted 
osmotic pump. Using a dose of 7.14 mg/kg (based on a rat weight of 350 g) there was a 
visible reduction in T1-relaxation in the hippocampus. The concentration used was the 
lowest systemic concentration applied in any MEMRI study (Lee et al., 2005). Most 
systemic studies use doses of 9-175 mg/kg. Compared to other studies, it was shown that 
a dose of 7.14 mg/kg did not produce sufficiently large changes in all brain areas. With 
this low concentration, all neurotoxic effects were avoided. Although from Chapter 2, it 
is clear that there are still toxicity issues to consider.  
 
4.2.2 Toxicity 
 
 Some issues of toxicity from both the systemic and direct applications were 
experienced. Work in Chapter 2 revealed that a concentration of 100 mM Mn caused a 
lesion in the rat’s brain. Surprisingly, there were no adverse effects on behavior that 
could be detected using the single pellet reaching task. However, the local toxicity of the 
injections may still need to be considered, depending on the application. A recent study 
tracing sensorimotor connections in the rat brain reported that acute injections of 100 mM 
MnCl2 solutions in brain parenchyma cause glial reaction for Mn loads above 8 nmol and 
neuronal death for loads at or above 16 nmol (Canals et al., 2008). 
 Histological results from work in Chapter 3 showed no indication of neural 
toxicity. However, it was observed that the rats lost, on average, 8 grams of body weight 
with the highest weight loss being 20 grams. This could indicate that the systemic method 
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of Mn infusion may be more stressful on the rats compared to the direct infusion. 
Systemic administration may prove to be more toxic because of the number of organs and 
systems, which the solution surpasses in order to reach its destination. This has been 
shown in previous studies using systemic applications (Eschenko et al., 2010, Jackson et 
al., 2011). The direct injection using an osmotic pump showed no significant effect on the 
rat’s body weight during the course of the study, including during the single pellet 
reaching task (Figure 2.9). Although the methods used were targeting different locations, 
both experiments used a slow release technique via an osmotic pump. 
 
4.2.3 Advantages and Disadvantages of the Use of Osmotic Pumps 
 One can now also consider, as it is becoming more popular, a slow release 
technique of administering Mn through the use of an osmotic pump. Both experiments in 
Chapter 2 and Chapter 3 made use of the osmotic pump to deliver Mn. As with all 
methods, there are many benefits and downfalls to this technique. Osmotic pumps come 
in a variety of sizes with different volumes, rates and durations for the administration of 
Mn solution. This is both a benefit and a deterrent as it limits the range of concentrations 
and volumes. It also allows for the tracking of enhancement due to changes in Mn 
concentration over time. Furthermore it decreases the susceptibility to toxicity issues 
which could arise from using bolus injections.  
In Chapter 2, it was shown that a concentration of 0.85 mM can be delivered 
safely to the rat brain using an osmotic pump. In a neuronal tract tracing study, it was 
demonstrated that Mn doses that resulted in dramatic cortical lesions when injected 
acutely into the brain parenchyma, can be safely applied to the brain when delivered from 
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low concentrated solutions with constant and extremely slow infusion rates. Suggesting 
that under such conditions Mn
2+
 is continuously transported away from the infusion site 
by neurons and detoxified glial cells, both factors contribute to prevent the tissue 
concentration to reach the toxic threshold (Canals et al., 2008). Canals et al. (2008) also 
found that the pump delivery method did not produce any adverse effects compared to the 
acute method. 
 In Chapter 3, it was shown that a concentration of 100 mM can be applied 
systemically with the use of an osmotic pump. However, because of the set volume and 
duration of the osmotic pumps, it is difficult to increase the concentration without 
compromising osmolarity. As shown in Chapter 3, the highest dose that would match 
osmolarity in the 200 µl pumps was around 7.14mg/kg. From the current literature, it is 
understood that in order to decrease toxicity, solutions should be equal to the osmolarity 
of the body (Eschenko et al., 2010). Therefore, a concentration of 100 mM in a 200 µL 
solution was used, which matched this osmolarity of 300 mOsm. Conversely, 
concentrations higher than 100 mM have been used in other studies. Recently, one study 
showed that osmotic pumps are suitable for delivering up to 30 mg/kg Mn within 24 
hours in MEMRI studies using rodent models that address anatomical imaging, tract 
tracing and other neurological diseases (Sepulveda et al., 2012). This group used a larger 
osmotic pump with a volume of 2 ml.  Another study achieved a significantly higher dose 
of Mn (180 mg/kg) than that employed in previous studies without any observable toxic 
effects on animal physiology or behavior (Mok et al., 2012). The pump volume used in 
this study was not stated; therefore it is unclear whether or not osmolarity was matched. 
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Although the pumps may compromise osmolarity, they are still very efficient at reducing 
toxic effects.  
 Eschenko et al. (2010) showed the importance of osmotic pumps to reduce toxic 
effects of Mn. Multiple injections conducted intraperitoneally in awake animals or 
intravenously in anesthetized animals was shown to be too intrusive for some behavioral 
studies (Eschenko et al., 2010). These authors then used IP osmotic pumps to deliver a 
total of 80 mg/kg of MnCl2 over 7 days and found no decreases in motor performance. In 
contrast, an equivalent single bolus dose administered systemically was found to reduce 
wheel running, as well as food intake and body weight (Eschenko et al., 2010). This 
study showed the importance of the use of an osmotic pump to achieve continuous slow, 
systemic release of Mn in rats. The method of Mn infusion via osmotic pump 
implantation is thus less disruptive to the animal’s mobility and could be very beneficial 
in studies of animal behavior. 
 Taken together, results from both studies indicate that a low concentration slowly 
infused into the lateral ventricles is suitable for a study of behavior and structure. We 
showed that for focal infusions concentrations of 0.85 mM Mn can be safely used. From 
the issues of toxicity, it was shown that systemic administration may cause more stress on 
the animal as the rats lost weight, whereas those who had focal infusion maintained their 
weight. There are also methods which can enable one the use of lower concentrations but 
achieve higher resolutions. These are technical issues which are discussed below. 
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4.3 Technical Considerations  
 In spite of the vast results, there were some technical difficulties that should be 
noted. Chapter 2 indicated that images obtained on some days had artifacts and were not 
useable. Chapter 3 discussed issues arising from the resolution obtained in the MRI 
images. First, it was difficult to determine the hippocampal boundaries on the images 
making it difficult to determine accurate hippocampal volume. This was due to a low 
contrast-to-noise ratio making it difficult to detect boundaries in regions with similar 
SNR. Second, the SNR obtained with the control images (taken a month after TPS rats 
were imaged) was of better quality. The variability in image quality was most likely due 
to an internal or external variable noise source beyond my control. Issues with the 
hardware and coil were faced during both studies presented here. 
 One issue concerns the use of a surface coil for signal detection. The advantage of 
this small surface coil was the high sensitivity close to the coil and the small area from 
where noise is received. Both of these factors contribute to good SNR. However, the 
sensitivity is highly inhomogeneous and results in a decreasing signal as a function of 
distance from the coil (Chuang and Koretsky, 2006). This leads to signal gradients in the 
image which degrades contrast to noise with depth and may affect volumetric 
measurements. Signal intensity was also sensitive to changes in tuning and matching of 
the coil, inhomogeneities in the excitation field (B1), receiver gain, and receive coil 
sensitivity. Our system has a manual setup, and all parameters need to be carefully set. 
 The issues above could also be present because the data were acquired with an 
MRI scanner that is considered to be of relatively low magnetic field strength. Most 
studies in MEMRI use a scanner of higher field strength (>4.7 T used in this study). 
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Achieving a high-field MRI is driven by the benefits of possibly higher signal-to-noise 
ratio, contrast-to-noise ratios and resolution for selected applications. In most cases, these 
benefits will enable higher spatial and/or temporal resolution than formerly possible with 
MRI. This is another factor which should be considered when choosing the concentration 
of Mn which should be used. MRI magnets of higher field strength (7 T and higher), are 
able to detect changes in T1 relaxation better than those of lower field because the normal 
tissue T1 is prolonged and the SNR is also higher at greater magnetic field strengths. It is 
therefore important to consider the equipment used to best suit the methodology applied. 
 Sampling at higher resolutions could also improve visualization of fine structures, 
such as full hippocampi. However, sampling at higher resolution also requires prolonged 
scanning time and hence extended anesthesia of the animal. Thus, the advantages of high 
resolution and the disadvantage of prolonged anesthesia have to be counterbalanced and 
adjusted to experimental demands. Furthermore, sampling at higher resolution also 
decreases SNR. However, smaller and more focal surface coils help in reducing this 
penalty as it decreases noise that could be detected from other structures. Technical 
advances in the field of imaging sequences for small animal MRI over the last few 
decades, the combination of different acquisition techniques, such as T1 mapping, and 
the adjusted scanning parameters for MEMRI should lead to a considerable improvement 
of images obtained using MEMRI (Lee et al., 2005; Chuang and Koretsky, 2006). 
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4.4 Conclusions 
 MEMRI has proven to be an asset to many studies in Neuroscience. These include 
studies of cytoarchitecture (Aoki et al., 2004), tract tracing (Chuang et al., 2006) and 
brain mapping (Eschenko et al., 2010) to name a few. The experiments in this thesis 
established two methods of Mn delivery, systemic and focal infusion. Also, an 
application for the use of MEMRI for volumetric analysis was successfully demonstrated. 
From the studies conducted here, it is evident that MEMRI has many advantages. 
MEMRI enabled a relatively quick overview of the whole brain in vivo to identify regions 
of the brain. Most studies lack the great advantage of MEMRI to measure structural 
neuroanatomy in vivo. Most importantly, MEMRI allowed for longitudinal studies which 
could give more detailed insight into the effects of training and learning on 
neuroanatomy. Overall, MEMRI has proved to be an invaluable tool in the field of 
neuroscience. 
 
4.5 Future Directions 
 Many directions for future studies were introduced in Chapters 2 and 3. In 
general, attempts should be made to increase the sensitivity of MEMRI by optimizing the 
MRI hardware, MRI sequences and data analysis to allow for using the lowest possible 
Mn concentration for a specific biological question. The goal of establishing the MEMRI 
method has been to enable longitudinal studies without disturbing regional functionality. 
This requires further detailed investigation of Mn toxicology in terms of behavior and 
neurophysiological consequences. Also, as with most animal research, finding 
applications to human studies should also be considered. Several human Mn-based 
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contrast agents have been developed. GE Healthcare developed Teslascan for liver 
imaging (which has been discontinued since) (Vitellas et al., 2001). Currently, Eagle 
Vision Pharmaceutical Corp. (Exton, PA, USA) is testing another Mn-based contrast 
agent called SeeMore for heart imaging (Storey et al., 2006). However, despite these 
advancements, it is unknown if MEMRI for brain imaging will ever be used in humans. 
For now, however, animal studies are vital to improve overall understanding of MEMRI 
and its applications in brain imaging. 
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APPENDIX A: Single Pellet Reaching Task Rating Scale  
 
 
 
 
1. Orient  -Head oriented to target _______ _______ _______ 
 -sniffing _______ _______ _______ 
     
2. Limb Lift  -body weight shift to back _______ _______ _______ 
 -hindlimbs aligned with body _______ _______ _______ 
 -limb moves forward  _______ _______ _______ 
 -digits on midline _______ _______ _______ 
     
3. Digits Close -palm supinated, semi-in _______ _______ _______ 
 -digits semiflexed _______ _______ _______ 
     
4. Aim -elbows come in  _______ _______ _______ 
 -palm in midline _______ _______ _______ 
     
5. Advance -elbow in  _______ _______ _______ 
 -limb forward _______ _______ _______ 
 -limb directed to target _______ _______ _______ 
 -head and upper body raised _______ _______ _______ 
 -body weight shift front _______ _______ _______ 
 -body weight shift lateral  _______ _______ _______ 
     
6. Digits Open  -digits open  _______ _______ _______ 
 -discrete limb movement  _______ _______ _______ 
 -not fully protonated  _______ _______ _______ 
     
7. Pronation -elbow out  _______ _______ _______ 
 -palm down in arpeggio _______ _______ _______ 
     
8. Grasp  -arm still _______ _______ _______ 
 -digits close _______ _______ _______ 
 -hand lifts _______ _______ _______ 
     
9. Supination I -elbow in _______ _______ _______ 
 -palm medially before leaving slot  _______ _______ _______ 
 -palm turned 90
o
 _______ _______ _______ 
     
10. Sup. II -head points down _______ _______ _______ 
 -body horizontally _______ _______ _______ 
 -palm straight up _______ _______ _______ 
 -distal limb movement  _______ _______ _______ 
     
11. Release  -open digits  _______ _______ _______ 
 -puts food in mouth  _______ _______ _______ 
 -head and upper body lowered  _______ _______ _______ 
 -raises other paw _______ _______ _______ 
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APPENDIX B: Protocol for Cresyl Violet Histology  
 
 
Cresyl Violet Histology  
 
Sequence for dipping slides: 
 
           START 
6 
Cresyl  
1min PRN 
(as needed) 
5 
dH2O 
1min 
4 
dH2O 
1min 
3 
70% EtOH  
2min 
2 
95% EtOH 
2min 
1 
Abs EtOH 
2min 
7 
dH2O 
rinse 
8 
70% EtOH 
2min 
9 
95% EtOH 
2min 
10 
Abs EtOH  
2min 
11 
Diff.  
2 min PRN 
12  
95% EtOH 
30 sec 
16 
Mount in 
HemoDe 
Transfer to 
Fume Hood 
Keep in 
HemoDe 
15  
HemoDe 
5min  
14  
HemoDe 
(solvent) 
5min 
13 
Abs EtOH 
1min 
 
END 
 
